Ubs Group Ag Edesa Biotech, Inc. Transaction History

Ubs Group Ag

16 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 09, 2023	BUY	$0.63 - $0.99 $3,403 - $5,348	5,403 Added 16372.73%	5,436 $3,000
Q2 2023 Aug 11, 2023	SELL	$0.77 - $1.16 $4,365 - $6,576	-5,669 Reduced 99.42%	33 $0
Q1 2023 May 12, 2023	BUY	$0.91 - $2.63 $5,158 - $14,909	5,669 Added 17178.79%	5,702 $5,000
Q3 2022 Nov 10, 2022	SELL	$1.39 - $9.94 $1,484 - $10,615	-1,068 Reduced 97.0%	33 $0
Q2 2022 Aug 10, 2022	SELL	$1.47 - $2.94 $4,302 - $8,605	-2,927 Reduced 72.67%	1,101 $2,000
Q1 2022 May 16, 2022	BUY	$2.72 - $5.97 $3,285 - $7,211	1,208 Added 42.84%	4,028 $12,000
Q4 2021 Feb 14, 2022	SELL	$5.17 - $8.65 $13,178 - $22,048	-2,549 Reduced 47.48%	2,820 $16,000
Q3 2021 Nov 15, 2021	BUY	$4.2 - $11.92 $6,678 - $18,952	1,590 Added 42.07%	5,369 $39,000
Q2 2021 Aug 13, 2021	BUY	$4.93 - $6.69 $18,467 - $25,060	3,746 Added 11351.52%	3,779 $20,000
Q4 2020 Feb 11, 2021	SELL	$4.25 - $8.14 $5,414 - $10,370	-1,274 Reduced 97.48%	33 $0
Q3 2020 Nov 12, 2020	SELL	$4.65 - $9.45 $8,802 - $17,888	-1,893 Reduced 59.16%	1,307 $11,000
Q2 2020 Jul 31, 2020	BUY	$2.0 - $6.62 $4,330 - $14,332	2,165 Added 209.18%	3,200 $16,000
Q1 2020 May 01, 2020	BUY	$1.64 - $4.09 $1,518 - $3,787	926 Added 849.54%	1,035 $2,000
Q4 2019 Feb 14, 2020	SELL	$3.94 - $6.42 $4,534 - $7,389	-1,151 Reduced 91.35%	109 $0
Q3 2019 Nov 14, 2019	BUY	$3.39 - $7.52 $996 - $2,210	294 Added 30.43%	1,260 $8,000
Q2 2019 Aug 14, 2019	BUY	$3.82 - $11.7 $3,690 - $11,302	966 New	966 $7,000

Ticker EDSA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 15,462,300
Market Cap $28.6M
Description
Edesa Biotech, Inc., a biopharmaceutical company, engages in acquiring, developing, and commercializing clinical-stage drugs for inflammatory and immune-related diseases with clear unmet medical needs. Its lead product candidates are EB05, a monoclonal antibody, which is in Phase 3 clinical study for the treatment of acute respiratory distress s...

Get notified when there are updates to the investment portfolio of Ubs Group Ag, based on Form 13F filings with the SEC.

Stay updated on Ubs Group Ag with notifications on news.